1. Yoshino, J., Mills, K. F., Yoon, M. J., & Imai, S. (2011). “Nicotinamide mononucleotide, a key NAD⁺ intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice.” Cell Metabolism, 14(4), 528–536.
2. Gomes, A. P., Price, N. L., Ling, A. J., et al. (2013). “Declining NAD⁺ induces a pseudohypoxic state disrupting nuclear-mitochondrial communication during aging.” Cell, 155(7), 1624–1638.
3. Imai, S., & Guarente, L. (2014). “NAD⁺ and sirtuins in aging and disease.” Trends in Cell Biology, 24(8), 464–471.
4. Zhang, H., Ryu, D., Wu, Y., et al. (2016). “NAD⁺ repletion improves mitochondrial and stem cell function and enhances life span in mice.” Science, 352(6292), 1436–1439.
5. Airhart, S. E., Shireman, L. M., Risler, L. J., et al. (2017). “An open-label, non-randomized study of the pharmacokinetics of the dietary supplement nicotinamide riboside and its effects on blood NAD⁺ levels in healthy volunteers.” American Journal of Clinical Nutrition, 105(3), 504–511.